- Home
- / Jounce Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jounce Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.9
2023-05-05
Market Capitalization
$101.6 M
2023-05-05
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|
| General and administrative expense | 23.1M | 26.4M | 27.9M | 28.8M | 29.0M | 31.0M |
| Operating expense total | 90.9M | 96.5M | 95.1M | 107.5M | 134.2M | |
| EBIT | (19.2M) | (31.3M) | 52.8M | (45.1M) | (91.1M) | (52.2M) |
| Interest expense | 2.8M | |||||
| Income tax expense | 36.0K | 46.0K | 46.0K | 14.0K | 15.0K | 135.0K |
| Net Income | (16.4M) | (27.4M) | 56.8M | (43.8M) | (90.9M) | (50.9M) |
| EPS | (1.0) |